Karl-Georg Fischer, Barbara Deschler, Michael Lübbert. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntigens/therapeutic useAutoantibodies/bloodAutoantibodies/immunologyAutoimmune Diseases/bloodAutoimmune Diseases/complicationsAutoimmune Diseases/drug therapyAutoimmune Diseases/therapyBlood Coagulation Factors/therapeutic useButtocksCyclophosphamide/therapeutic useFactor VII/therapeutic useFactor VIII/antagonists & inhibitorsFactor VIII/immunologyFatal OutcomeHematoma/drug therapyHematoma/etiologyHematoma/therapyHemorrhage/drug therapyHemorrhage/etiologyHemorrhage/prevention & controlHemorrhage/therapyHumansImmunosuppressive Agents/therapeutic useInjections, Intramuscular/adverse effectsLung Diseases/drug therapyLung Diseases/etiologyLung Diseases/prevention & controlLung Diseases/therapyMalePartial Thromboplastin TimePlasmapheresisPrednisone/therapeutic useRecombinant Proteins/therapeutic useRituximabVincristine/therapeutic use
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntigensAutoantibodiesBlood Coagulation FactorsImmunosuppressive AgentsRecombinant Proteinsfactor VII clotting antigenRituximabVincristineCyclophosphamideFactor VIIFactor VIIIanti-inhibitor coagulant complexPrednisone
Year: 2003 PMID: 12707227 DOI: 10.1182/blood-2002-12-3920
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113